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Abstract: Obstructive sleep apnea syndrome (OSAS) is 
characterized by the recurrent cessation (apnea) or reduc-
tion (hypopnea) of airflow due to the partial or complete 
upper airway collapse during sleep. Respiratory distur-
bances causing sleep fragmentation and repetitive noc-
turnal hypoxia are responsible for a variety of nocturnal 
and daytime complaints of sleep apnea patients, such as 
snoring, daytime sleepiness, fatigue, or impaired cogni-
tive functions. Different techniques, such as magnetic res-
onance imaging, magnetic resonance spectroscopy, and 
positron emission tomography, are used to evaluate the 
structural and functional changes in OSAS patients. With 
quantitative electroencephalographic (qEEG) analysis, 
the possible existence of alterations in the brain electrical 
activity of OSAS patients can be investigated. We review 
the articles on qEEG results of sleep apnea patients and 
summarize the possible explanations of these qEEG meas-
ures. Finally, we review the impact of continuous positive 
airway pressure (CPAP) treatment on these alterations to 
assess whether CPAP use can eliminate alterations in the 
brain activity of OSAS patients.
Keywords: continuous positive airway pressure; noctur-
nal hypoxemia; sleep fragmentation; slowing ratio; spec-
tral analysis.
Introduction
Obstructive sleep apnea-hypopnea 
syndrome (OSAHS)
Obstructive sleep apnea syndrome (OSAS) is the most 
common type of sleep-related breathing disorders. OSAHS 
is characterized by the recurrent episodes of the partial 
or complete upper airway collapse during sleep. The col-
lapse leads to a reduction (hypopnea) or complete (apnea) 
cessation of airflow despite ongoing inspiratory efforts 
(De Baker, 2006). Reduced or absent airflow is accom-
panied by oxygen desaturation and terminated by brief 
microarousals, which result in sleep fragmentation and 
diminished amount of slow-wave and rapid eye move-
ment (REM) sleep (Deegan and McNicholas, 1995). Hyper-
capnia, swings in intrathoracic pressure, and increased 
sympathetic activity are also the results of repetitive upper 
airway collapse. Clinically, OSAS is characterized by the 
occurrence of excessive daytime sleepiness, loud snoring, 
breathing interruptions, and frequent awakenings due to 
gasping (Epstein et al., 2009). OSAS affects approximately 
2%–14% of adults (Young et  al., 2002) and older adults 
aged 65 years and above have an increased prevalence of 
sleep apnea (Shochat and Pillar, 2003).
Increased body mass index, neck circumference, 
and waist-to-hip ratio are common risk factors for OSAS 
(Young et al., 2004). Craniofacial and upper airway mor-
phology also plays an important role in the occurrence of 
sleep apnea (Dempsey et al., 2002). Patients with maxillo-
mandibular malformations, adenotonsillar enlargement, 
increased uvula size, long soft palate, or other upper 
airway abnormalities often suffer from OSAS.
Untreated sleep apnea can increase the risk of hyper-
tension, diabetes, or heart disease and heart failure (Ho and 
Brass, 2011) and there is emerging evidence that the risk 
of stroke is also higher in OSAS patients independently of 
traditional risk factors (Mohsenin, 2015). Excessive daytime 
sleepiness is a major consequence of OSAS; reduced wake-
fulness and vigilance and abnormal daytime tiredness 
contribute to higher frequency of traffic and occupational 
accidents among OSAS patients, but impaired cognition, 
mood disorders, poor social functioning, and reduced 
quality of life are also common complaints of OSAS patients 
(Findley et al., 1986; Greenberg et al., 1987; Lloberes et al., 
2000; Akashiba et al., 2002; Melamed and Oksenberg, 2002).
Diagnosis and treatment of OSAHS
The diagnosis of OSAS is based on the evaluation of clini-
cal symptoms and objective sleep study findings. Patients 
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and bedpartners should be asked about nocturnal sleep 
and daytime complaints. The most widely used test to 
screen subjective daytime sleepiness is the Epworth 
Sleepiness Scale (ESS). The Maintenance of Wakefulness 
Test (MWT) and the Multiple Sleep Latency Test (MSLT) 
objectively measure sleepiness and alertness (Mannarino 
et al., 2012).
To confirm the suspicion of OSAS, nocturnal, labo-
ratory-based polysomnography (PSG) remains the gold 
standard. While the patient sleeps, several parameters 
(i.e. electrocardiogram, blood oxygen saturation, elec-
troencephalogram, electro-oculogram, nasal and oral 
airflow, chest and abdominal wall movements, and elec-
tromyogram) are recorded and measured. The diagnosis 
and severity of OSAS is based on the apnea-hypopnea 
index (AHI), which is the number of obstructed breathing 
events per hour of sleep. OSAS is defined as an AHI of 5 
or greater with associated clinical symptoms (e.g. exces-
sive daytime sleepiness, fatigue, or impaired cognition) or 
as an AHI of 15 or greater regardless of associated symp-
toms (Park et al., 2011). According to the third edition of 
the International Classification of Sleep Disorders, OSAS 
can be diagnosed in the presence of selected risk factors 
and comorbidities (i.e. high blood pressure or coronary 
heart disease, type II diabetes, and mood disorders) even 
for otherwise asymptomatic patients with an AHI of 5–15 
(Stuck and Maurer, 2016). An AHI of 5–14 is classified 
as mild sleep apnea; for moderate severity, AHI should 
be between 15 and 29; in severe OSAS, AHI is above 30 
(McNicholas, 2008).
Continuous positive airway pressure (CPAP) is the 
primary treatment modality in patients with severe OSAS 
(Lévy et al., 2015). CPAP prevents upper airway collapses, 
improves oxygen saturation, and reduces sleep fragmen-
tation. In the mild to moderate form of OSAS, the use 
of mandibular advancement devices is recommended 
( Randerath et  al., 2011). Oral appliance can be an alter-
native approach in CPAP intolerance or CPAP failure. Sur-
gical procedures, such as maxillomandibular osteotomy, 
are also efficient in patients who refuse conservative treat-
ment. Weight loss, postural treatments, and sleep hygiene 
can be also recommended in selected cases.
Quantitative electroencephalo-
graphy (qEEG) analysis in OSAS 
patients
The effects of OSAS on brain structure and function were 
investigated in several previous studies using different 
techniques, i.e. structural and functional magnetic reso-
nance imaging (MRI), magnetic resonance spectroscopy 
(MRS), positron emission tomography (PET), and event-
related potentials (Mohsenifar et al., 1994; Kamba et al., 
1997; Macey et  al., 2002; Morrell et  al., 2003; Raggi and 
Ferri, 2012; Park et al., 2016).
EEG is an indispensable tool in both research and 
clinical practice, because the electromagnetic oscillations 
of the brain cannot be detected by any other investigating 
methods, except for magnetoencephalography. In addi-
tion, EEG has excellent temporal resolution in millisecond 
scale. Conventional visual EEG analysis is not eligible to 
assess those subtle details of the electrical activity of the 
brain, which might be relevant in research or clinical prac-
tice. qEEG techniques can provide additional information 
for the detection of subtle brain abnormalities associated 
with OSAS.
In recent years, research groups performed a quantita-
tive analysis of both wake and sleep EEG of OSAS patients. 
qEEG techniques were used to characterize the changes 
in brain electrical activity, which accompany sleep frag-
mentation, daytime sleepiness, repetitive nocturnal 
hypoxemia, or neurocognitive deficits. Studies were also 
conducted to explore whether qEEG parameters change 
after CPAP treatment of sleep apnea patients.
qEEG analysis of background EEG activity 
in untreated OSAS patients
Morisson et  al. (1998) hypothesized that the deficit in 
executive functions, which was often reported in OSAS 
patients, may be associated with frontal lobe dysfunc-
tion. EEG recordings of sleep apnea patients and normal 
controls were compared to calculate the slowing ratio 
(ratio of slow frequencies to fast frequencies). Changes in 
this ratio could reflect EEG slowing due to an increase in 
slow frequencies, a decrease in fast frequencies, or both. 
During wakefulness, EEG slowing was observed over all 
cortical regions, not only over frontal cortex. In another 
study of Morisson et al. (2001), a higher slow activity to 
fast activity ratio was described during both wakefulness 
and REM sleep for all cortical regions pooled in untreated 
OSAS patients. Consistent with the previous findings of 
Morisson et al. (1998, 2001), Mathieu et al. (2007) reported 
slowing of the EEG across all cortical regions in OSAS 
patients compared to healthy controls with EEG spectral 
analysis. They also investigated if age interacted with the 
severity of cortical slowing in OSAS as increased slow 
activity was described in normal subjects with advancing 
age using qEEG analysis (Breslau et al., 1989). Comparing 
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younger (25–50 years) to older (51–72 years) OSAS patients, 
no age-related changes could be identified in EEG activity. 
Xiromeritis et al. (2011) could detect a significant increase 
in relative θ and δ power in the parietal, temporal, and 
occipital regions in severe OSAS patients compared to 
normal subjects, but no significant differences were 
observed in the relative power of the frequency bands 
in patients with mild and moderate OSAS compared to 
healthy controls.
Because waking EEG patterns of sleep apnea patients 
have many similarities with EEG changes in normal sub-
jects under hypobaric hypoxia (Kraaier et  al., 1988), i.e. 
increased slow activity and decreased α and β activities, 
nocturnal hypoxia was suggested as a possible explana-
tion for EEG slowing in OSAS patients. Morisson et  al. 
(1998) found a weak positive correlation between wake 
EEG slowing and the degree of oxygen desaturation 
during sleep. Morisson et al. (2001) could not reproduce 
the previous findings, as EEG slowing of untreated sleep 
apnea patients and the severity of nocturnal hypoxemia 
were independent. Xiromeritis et al. (2011) could confirm 
the relationship between nocturnal hypoxia and brain 
dysfunction with consequent EEG slowing. In their analy-
sis, the desaturation index of OSAS patients positively 
correlated with the θ relative power in frontal, central, 
parietal, temporal, and occipital areas and also with the δ 
relative power in central, parietal, temporal, and occipital 
areas. In contrast to the possible role of hypoxia in EEG 
slowing, Wang et al. (2015) demonstrated that hypercap-
nia but not hypoxia might play a key role in slowing of the 
EEG (increased δ/α ratio) in healthy individuals. In OSAS 
patients, a correlation between hypercapnia and qEEG 
changes was not examined.
Another possible explanation of slowing in awake EEG 
could be sleep fragmentation that may affect the restora-
tive functions of sleep. As a consequence, OSAS patients 
have excessive daytime sleepiness or reduced vigilance. In 
healthy individuals, increased θ activity and decreased α 
activity were reported when drowsiness was manifested 
(Broughton and Hasan, 1995). Sforza et  al. (2002) com-
pared the absolute EEG power values of sleepy and non-
sleepy OSAS patients and found that sleepy patients had 
greater θ and slow α powers than patients without exces-
sive daytime sleepiness, but the differences did not reach 
statistical significance. The authors could not disclose any 
significant relationship between waking EEG powers and 
any markers of sleep fragmentation, confirming that these 
indices play little, if any, role in the occurrence of slowing 
of the EEG. Similarly, Morisson et al. (1998) also failed to 
demonstrate a correlation between diffused EEG slowing 
and objective sleepiness.
In contrast, the results of Mathieu et  al. (2007) 
support the hypothesis that diffused cortical slowing is 
a manifestation of sleep fragmentation, as they found a 
relationship between EEG slowing ratio in all investigated 
cortical regions and sleep fragmentation (indexed by 
microarousal).
The previously mentioned studies all could confirm 
slowing in awake EEG of OSAS patients, but Lee et  al. 
(2008) could not detect any changes in slow waves in sleep 
apnea patients. The explanation of this finding might be 
that this study group compared patients with mild OSAS 
to severe OSAS patients, not to normal subjects.
To investigate the changes in brain electrical activ-
ity in 3D space, an EEG source localization method, low- 
resolution electromagnetic tomography (LORETA), was 
also applied by research groups. Lee et  al. (2008) dem-
onstrated a decreased α activity at the right posterior cin-
gulate gyrus in cases with severe OSAS compared to mild 
OSAS. The authors concluded that the α reduction is a 
sign of brain dysfunction from hypoxic damage caused by 
repeated chronic hypoxia and the dysfunction of the iden-
tified brain region may play a role in cognitive deficits. In 
contrast to the previous findings, Toth et al. (2009) observed 
a significantly increased α2 (10.5–12 Hz) frequency activity 
bilaterally in the precuneus and posterior cingulate cortex 
with LORETA by comparing OSAS patients to normal sub-
jects. These alterations were also thought to reflect the 
effect of intermittent chronic hypoxia in regions associated 
with influencing emotional regulation, long-term memory, 
and the default mode network. Significantly overlapping 
with the regions where abnormalities were identified by 
Lee et al. (2008) and Toth et al. (2009), Jones et al. (2014) 
found circumscribed broadband reduction in EEG power 
in OSAS subjects relative to controls using high-density 
sleep EEG recordings. According to the authors, regional 
deficits may be a useful clinical marker for neural disrup-
tion in OSAS and high-density EEG is sensitive enough to 
detect early pathological cortical changes.
qEEG analysis of apnea and arousal
qEEG was also used to investigate the changes that 
occur during transient hypoxic events that are induced 
by apnea episodes. Svanborg and Guilleminault (1996) 
studied 16-channel EEG during periods of sleep apneas 
in REM and non-REM (NREM) sleep. The δ-band activ-
ity increased progressively and was generalized over the 
scalp during NREM apneas, and δ amplitudes tended to 
have a maximum in the posterior frontal, central, and 
parietal regions. Also, during REM apneas, increased δ 
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activity was present, but it was much less marked than 
during NREM apneas and occurred without progression. 
Morisson et  al. (1998) investigated samples from REM 
sleep EEG of OSAS patients in the middle of the apnea epi-
sodes. Compared to normal controls, they also described 
EEG slowing in REM sleep during apneic pauses over the 
frontal, central, and parietal regions. Walsleben et  al. 
(1993) reported decreased total brain activity in associa-
tion with apneic events.
A relationship between EEG changes during apnea 
episodes and accompanying oxygen desaturations was 
investigated by Svanborg and Guilleminault (1996). The 
authors concluded that there were no significant corre-
lations between increases in δ activity during REM and 
NREM apneas and degree of desaturation, which indi-
cates that the δ increases in REM and NREM apneas might 
not be caused by hypoxemia. This finding is in agreement 
with the results of Morisson et al. (1998) who also did not 
find a correlation between EEG slowing of REM apneic 
pauses and degree of oxygen desaturation. Apnea and 
hypopnea-induced cortical arousals cause sleep fragmen-
tation, hence daytime sleepiness, but a subset of apneas 
and hypopneas are not terminated by visible cortical 
arousals. Dingli et al. (2002) tested whether qEEG would 
be a useful tool for detecting nonvisible signal changes in 
brain activity related to apnea/hypopnea termination.
During NREM sleep when arousals were visible, a 
decrease in normalized θ power was detected, which was 
derived from the increase in α and σ power. When arousals 
were not visible in NREM sleep, the θ fraction decreased 
as a result of δ power increase. During REM sleep arousal, 
terminating apneas/hypopneas were associated with a 
decrease in θ power fraction alone. REM-related apneas/
hypopneas, which were not terminated by visible arous-
als, were not associated with any significant spectral 
power changes.
qEEG in OSAS patients with CPAP 
treatment
CPAP is currently the most effective treatment for OSAS. 
Studies were conducted to investigate whether EEG 
 abnormalities observed before treatment are reversible by 
comparing the results of qEEG analysis before and after 
CPAP use. If the EEG slowing is reversible, it might be 
the consequence of hypoxic brain dysfunction, and with 
the correction of hypoxia, the brain activity normalizes. 
Permanent EEG slowing can be a sign of possible brain 
damage.
Morisson et al. (2001) confirmed that after 6 months of 
CPAP treatment the slowing ratio and the absolute activity 
in the δ band returned to normal values for both wakeful-
ness and REM. Although the brain activity of sleep apnea 
patients normalized, patients’ daytime sleepiness was 
not completely recovered after CPAP treatment. Similar 
results were reported by Lee et  al. (2012). Assessing the 
qEEG changes after at least 3  months of CPAP therapy, 
EEG slowing was significantly improved across the cer-
ebral regions investigated and these improvements were 
associated with reductions in daytime sleepiness. In 
contrast to the results of Morisson et  al. (2001) and Lee 
et al. (2012), Xiromeritis et al. (2011) could demonstrate an 
increase of EEG slowing after 6 months of CPAP treatment. 
The authors could not give a clear explanation for the 
results. Six months of CPAP use improved daytime sleepi-
ness and EEG demonstrated a decrease in the α (frontal, 
central, and temporal areas) and θ (frontal areas) rela-
tive power. The β relative power was increased mainly in 
central brain areas and the δ relative power was increased 
in all brain areas. The authors concluded that hypoxia in 
patients with severe OSAS might be responsible for brain 
dysfunction, which could not be restored after 6 months 
of treatment.
After the initiation of CPAP use, rapid changes in 
brain electrical activity were described by Toth et  al. 
(2012). They performed LORETA analysis of sleep apnea 
patients after one night of CPAP therapy. The significant 
difference observed without CPAP treatment in the α2 
frequency range bilaterally in the precuneus, paracen-
tral, and posterior cingulate cortex vanished after CPAP 
initiation. According to the authors, this change might be 
considered as a first sign of elimination of chronic inter-
mittent hypoxia.
Conclusion
In this review, we summarized the results of studies that 
were conducted to quantitatively analyze EEG changes in 
adult OSAS patients before and after CPAP therapy. qEEG 
techniques have been particularly helpful in the detec-
tion of subtle alterations in brain electrical activity, which 
cannot be discovered with conventional visual analysis.
The most consistent finding in the evaluation of brain 
activity in untreated OSAS patients was diffused EEG 
slowing during wakefulness, and only a limited number 
of studies reported circumscribed changes in brain activ-
ity. It was hypothesized that the slowing in awake EEG is 
a consequence of sleep fragmentation, but the majority 
of studies could not prove any significant relationship 
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between waking EEG measures and any markers of sleep 
fragmentation. Increased awake slow EEG frequency in 
OSAS may represent drowsiness or reduced vigilance, 
which is a common complaint of sleep apnea patients, 
but studies have shown that neither objectively nor sub-
jectively measured sleepiness is associated with EEG 
slowing during wakefulness. As researchers suggested, an 
alternative possibility is that hypoxemia and recurrence 
of apneas would contribute to cerebral impairment and 
altered or damaged brain functions are reflected in the 
slowing of the EEG activity. CPAP treatment is proven to be 
effective in reversing respiratory impairments during the 
night, but CPAP therapy seems to be useful in correcting 
pretreatment qEEG abnormalities as well.
Further studies with the routine use of high-density 
EEG and advanced qEEG techniques on large groups of 
patients of similar age, disease severity, and comorbidity 
are needed to better understand the relationship between 
OSAS and changes in brain activity.
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